These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Tumor suppressor p53 but not cGMP mediates NO-induced expression of p21(Waf1/Cip1/Sdi1) in vascular smooth muscle cells. Ishida A, Sasaguri T, Miwa Y, Kosaka C, Taba Y, Abumiya T. Mol Pharmacol; 1999 Nov; 56(5):938-46. PubMed ID: 10531398 [Abstract] [Full Text] [Related]
10. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity. Coppock DL, Buffolino P, Kopman C, Nathanson L. Exp Cell Res; 1995 Nov 18; 221(1):92-102. PubMed ID: 7589260 [Abstract] [Full Text] [Related]
11. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation. Tanner FC, Boehm M, Akyürek LM, San H, Yang ZY, Tashiro J, Nabel GJ, Nabel EG. Circulation; 2000 May 02; 101(17):2022-5. PubMed ID: 10790340 [Abstract] [Full Text] [Related]
15. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. Liang YC, Lin-Shiau SY, Chen CF, Lin JK. J Cell Biochem; 1999 Oct 01; 75(1):1-12. PubMed ID: 10462699 [Abstract] [Full Text] [Related]